600380.SH
健康元
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 9.35
−5.36%Year over year
Reported trailing growth
- Revenue
- -3.4%
- EBITDA
- —
- EBIT
- -8.8%
- EPS
- -1.8%
- Free cash flow
- +26.9%
- Operating cash flow
- +15.0%
Forward estimates
Based on analyst estimates
- Revenue
- -80.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.9%
- EBITDA
- -0.0%
- EBIT
- -0.1%
- Net income
- -3.9%
- EPS
- -2.7%
- Free cash flow
- +3.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026